Key takeaways from UBS's market note for the broader outlook

What the bigger picture reveals from UBS's daily commentary

UBS publishes a daily note that addresses overnight market moves. A recent edition focused on a subdued start to the week, citing hotter-than-expected US inflation data, AI executives urging a slower pace of model development, and rising oil prices driven by fresh attacks in the Middle East. Much of this is likely to be transient by the end of the week. However, beneath these daily fluctuations, UBS highlights three points that remain relevant regardless of this week's events.

1. The risk is not a Fed rate hike, but a slowing economy.

The immediate reaction to stronger inflation figures is often concern that a Federal Reserve rate increase will negatively impact stocks. UBS's historical analysis suggests this focus may be misplaced. Rate increases only pose a genuine problem for equities when economic growth begins to weaken. Historically, these two factors have not moved in tandem; rate hikes and economic downturns have occurred on different schedules. UBS notes that the current economic environment remains robust, pointing to eight consecutive months of expansion in the ISM Manufacturing PMI, which tracks US factory activity. Historically, expansions in this index have lasted about three years on average since 1950. Their baseline forecast involves two more rate hikes in this cycle, which their models suggest would only reduce growth by a few tenths of a percentage point. The key lesson: when evaluating whether a tightening cycle threatens markets, growth data is more important than the rate hike itself.

• Why a Fed rate hike can't fix oil and diesel prices, but may still curb inflation

2. AI investment is not slowing; it is prompting calls for regulation.

Recent statements from AI executives advocating for a slower pace in developing advanced models might be interpreted as a sign that the AI capital expenditure boom is waning. UBS views this differently, seeing it as an effort to establish a regulatory framework that leading labs can accept, rather than a genuine reduction in ambition. The evidence they cite is tangible: token volumes, which measure usage of AI infrastructure, have increased roughly 176% since the end of June, while average pricing has dropped by about 42%. This indicates that usage is expanding faster than costs are falling. UBS maintains its projection that AI capital expenditure will grow 33% to USD 1.2 trillion by 2027. The message for investors: differentiate between calls for regulation and indicators of a true slowdown in demand—they are not equivalent signals.

3. Earnings growth continues to drive market performance.

Underlying UBS's positive outlook is a straightforward idea: a growing economy supports rising corporate profits. UBS forecasts S&P 500 earnings growth of 25% this year and 14% in 2027. They argue that as long as a recession is not imminent—which they do not anticipate given the expected shallowness of this rate-hiking cycle—this earnings growth should sustain equity gains even during periods of volatility. This is the metric to monitor above the more attention-grabbing daily data points: if the earnings growth forecast remains intact, the bullish case holds; if it begins to decline, that is the cue to reassess.

UBS's conclusion is that investors should remain invested through a diversified allocation that includes both structural themes, such as AI, and cyclical opportunities, with regional diversification adding further resilience. It is worth noting that this represents UBS's house view and forecast, not a guarantee. However, the framework they provide—focusing on growth over rate hikes, usage over rhetoric, and earnings over headlines—offers a useful perspective for interpreting market noise, not just this week.